Targeting CD47/SIRPα in Acute Myeloid Leukemia and Myelodysplastic Syndrome: Preclinical and Clinical Developments of Magrolimab.

ABSTRACT:

SUBMITTER: Haddad F 

PROVIDER: S-EPMC9153253 | biostudies-literature | 2021 May

REPOSITORIES: biostudies-literature